No end in sight: the skin cancer epidemic continues.

The incidence of nonmelanoma skin cancer (NMSC) continues to increase. Multiple reports from the United States and Europe suggest we are in the midst of an epidemic. European studies show substantial NMSC incidence increases during the last 2 decades. In the United States, a recent analysis of Medicare Claims data showed that procedures performed for NMSC nearly doubled from 1994 to 2006. From these data, the total number of new NMSC in 2006 was estimated to be 3,507,693. Procedure data for 2006-2008 from the 5% Medicare Claims sample dataset corroborate the reported trajectory of incidence increase. Destructions, excisions, and Mohs procedures for NMSC have increased by 2.6% per year during the last 2 years. On the basis of this current rate of increase, the annual incidence of NMSC in the United States in 2008 would be nearly 3.69 million. Recognizing the NMSC epidemic is critical as the incidence-and cost-will continue to increase.

[1]  A. Gavin,et al.  Skin cancer trends in Northern Ireland and consequences for provision of dermatology services , 2007, The British journal of dermatology.

[2]  J. Lear,et al.  Non-melanoma skin cancer , 2010, The Lancet.

[3]  D. Battistutta,et al.  Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group. , 1996, American journal of epidemiology.

[4]  K. Malinovszky,et al.  Changing trends in non‐melanoma skin cancer in South Wales, 1988–98 , 2000, The British journal of dermatology.

[5]  Jian Liu,et al.  Incidence of Nonmelanoma Skin Cancer in New Brunswick, Canada, 1992 to 2001 , 2007, Journal of cutaneous medicine and surgery.

[6]  B. Diffey,et al.  Skin cancer incidence and the ageing population , 2005, The British journal of dermatology.

[7]  P. Nelemans,et al.  Trends in the incidence of basal cell carcinoma by histopathological subtype , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  D. Brewster,et al.  Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992–2003 , 2007, The British journal of dermatology.

[9]  E. D. Smith,et al.  Cost of Nonmelanoma Skin Cancer Treatment in the United States , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[10]  S. Feldman,et al.  The economic impact of non-melanoma skin cancer: a review. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[11]  Brett M. Coldiron,et al.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006. , 2010, Archives of dermatology.

[12]  P. Buettner,et al.  Incidence rates of skin cancer in Townsville, Australia , 1998, International journal of cancer.

[13]  P. Buettner,et al.  Erratum in: Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998;78:587–93. , 2001 .

[14]  J. L. Smith,et al.  Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006 , 2011 .

[15]  L. Naldi,et al.  The epidemiology of skin cancer , 2002, The British journal of dermatology.

[16]  A. Katalinic,et al.  Epidemiology of cutaneous melanoma and non‐melanoma skin cancer in Schleswig‐Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer) , 2003, The British journal of dermatology.

[17]  W. F. Athas,et al.  Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  M. Karagas,et al.  Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA , 1999, International journal of cancer.

[19]  M A Weinstock,et al.  Nonmelanoma skin cancer in the United States: incidence. , 1994, Journal of the American Academy of Dermatology.